CHARLOTTESVILLE, Va. (WVIR) - In 2018, the University of Virginia Pediatrics Department performed 13 pediatric heart transplants. While risky and stressful, these transplants have given a new lease on life to children around Virginia. Graham Lighthiser came into the world as an early Christmas gift to his parents last year. Born six weeks premature, he spent the first month of …

Researchers at the University of Texas (UT) reported Tuesday that they have developed a vaccine that could arm the body to attack Alzheimer's plaques and tangles before they even start to shut down the brain. They hope to begin testing the vaccines in humans soon. Their new vaccine for the first time has targeted both amyloid-containing plaques and tau—both considered …

Digitalis lanata, the woolly foxglove, is the source of dioxin, a medication long used to treat heart conditions that has now been found to have potential for treating medulloblastoma, the most common malignant brain tumor in children. Credit: Michael Wolf via Wikimedia Commons Some drugs for heart disease might also work against brain cancer, according to an analysis by researchers …

Heart failure affects an estimated 5.7 million Americans and more than 26 million people globally, causing shortness of breath and tiredness among those affected as their heart struggles to pump blood around the body. One cause of severe heart failure that currently has a poor prognosis is a leaky valve, particularly the leakage of the mitral valve, which control's blood …

KOLKATA: Samiran Dutta, 52, became the first Kolkatan to undergo a heart transplant surgery at a city hospital. The organ, harvested in Andhra Pradesh’s Kakinada, was flown in to the city late on Sunday night. A chartered flight, carrying the heart touched down at NSCBI Airport at 11.45pm. The organ was brought to a hospital off EM Bypass through a …

A Japanese research team announced it will start human clinical trials for a new Parkinson’s disease treatment. On Monday, a team from Kyoto University’s Center for iPS Cell Research and Application announced it will begin testing the new treatment on humans after successful rounds of animal trials. The injected treatment uses stem cells to help those with Parkinson’s diseases and …

New technology is allowing doctors to treat heart failure patients with worsening symptoms before they appear physically sicker, giving patients a better quality of life. (Photo credit: WLOS Staff) ASHEVILLE, N.C. (WLOS) — New technology is allowing doctors to treat heart failure patients with worsening symptoms before they appear physically sicker, giving patients a better quality of life. "I couldn't …

July 20, 2018 A drug currently in clinical trials for treating symptoms of Parkinson's disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers. The drug, a member of a class of compounds known as phosphodiesterase (PDE) type I inhibitors, shows promising effects on dog and rabbit hearts, as …

Meganucleases were used to disable a gene in the livers of rhesus macaques. LAGUNA DESIGN/Science Source By Jocelyn KaiserJul. 9, 2018 , 11:25 AM For the first time, researchers have used gene-editing tools in adult monkeys to disable a gene throughout much of the liver. The approach lowered blood cholesterol levels, suggesting a treatment for heart disease. The study could …

Jess Davenport-Lee's heart could stop beating at any moment. The Auckland 24-year-old is largely house-bound these days, takes a defibrillator with her whenever she does manage to get out and has to have someone trained in CPR with her at all times. Her only hope of a normal life is a heart and liver transplant she has been waiting 14 …